Platelet membrane coated MOF/siRNA can specific-bind to the cancer cells, and reduce survivin (overexpressed in most breast carcinomas) expression level in human SK-BR-3 breast cancer cells and in vivo [185]. Here, BIRC5 is linked to breast carcinoma.